Skip to main content
. 2023 Dec 28;16(1):47. doi: 10.3390/pharmaceutics16010047
API active pharmaceutical ingredient
ASO antisense oligonucleotide
AUC area under the curve
BA bioavailability
C8 caprylic acid, octanoic acid
C10 capric acid, decanoic acid
COG cost of goods
cEt constrained ethyl
CPPs cell-penetrating peptides
cLogD calculated octanol-water distribution coefficient
cLogP calculated octanol-water partition coefficient
EDTA ethylenediaminetetraacetic acid
EPSA experimental polar surface area
FDA United States Food and Drug Administration
GalNAc N-acetylgalactosamine
GRAS generally recognized as safe
HBAs number of hydrogen bond acceptors
HBDs number of hydrogen bond donors
IJ intrajejunal
IV intravenous
MW molecular weight
MPSA molecular (3D) polar surface area in nonpolar environment
Ms microsomes
NAr number of aromatic rings
NMR nuclear magnetic resonance
LD50 median lethal dose
LPE lipophilic permeability efficiency
NF-kB nuclear factor kappa B
NOAEL no-observed-adverse-effect level
P450 cytochrome P450
P-gp P-glycoprotein
PO per oral
TPSA topological polar surface area
SC subcutaneous
siRNA small interfering RNA
SNAC salcaprozate sodium
TEER transepithelial electrical resistance
TNF-α tumor necrosis factor α
TPDs target protein degraders